Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for NTRB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
July 31, 2026 5.329M
April 30, 2026 5.99M
January 31, 2026 6.680M
October 31, 2025 7.549M
July 31, 2025 8.494M
April 30, 2025 5.103M
January 31, 2025 6.429M
October 31, 2024 11.23M
July 31, 2024 12.46M
April 30, 2024 13.36M
January 31, 2024 6.438M
October 31, 2023 5.711M
July 31, 2023 6.891M
April 30, 2023 7.720M
January 31, 2023 8.573M
October 31, 2022 9.732M
July 31, 2022 10.40M
April 30, 2022 11.08M
January 31, 2022 11.86M
October 31, 2021 14.32M
July 31, 2021 7.316M
April 30, 2021 7.836M
Date Value
January 31, 2021 7.112M
October 31, 2020 7.254M
July 31, 2020 1.297M
April 30, 2020 1.472M
January 31, 2020 0.1754M
October 31, 2019 1.073M
July 31, 2019 1.633M
April 30, 2019 2.084M
January 31, 2019 2.405M
October 31, 2018 2.420M
July 31, 2018 2.909M
April 30, 2018 -0.0489M
January 31, 2018 0.1215M
October 31, 2017 2.383M
July 31, 2017 2.490M
April 30, 2017 -0.0126M
January 31, 2017 0.0231M
October 31, 2016 -0.0292M
July 31, 2016 0.0005M
April 30, 2016 0.0358M
January 31, 2016 -0.0115M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M
Veru, Inc. 28.38M
Johnson & Johnson 84.97B
Eli Lilly & Co. 33.88B

Shareholders Equity (Quarterly) Related Metrics